Information Sheets for Institutional Review Boards and Clinical Investigators
Rockville, MD: Food and Drug Administration, 1995 October 1; 154p.
Showing items related by title, author, creator and subject.
Unknown author (United States Food and Drug Administration, 1994-08-24)
Disclosing Conflicts of Interest in Clinical Research: Views on Institutional Review Boards, Conflict of Interest Commmittees, and Investigators Weinfurt, Kevin P.; Friedman, Joëlle Y.; Dinan, Michaela A.; Allsbrook, Jennifer S.; Hall, Mark A.; Dhillon, Jatinder K.; Sugarman, Jeremy (2006-09)Strategies for disclosing investigators' financial interests to potential research participants have been adopted by many research institutions. However, little is known about how decisions are made regarding disclosures ...
A Study of Warning Letters Issued to Clinical Investigators and Institutional Review Boards by the United States Food and Drug Administration Gogtay, N J; Doshi, B M; Kannan, S; Thatte, U (2011-10)Warning letters (WLs) issued by the US FDA (United States Food and Drug Administration) mention the nature of violations by clinical investigators and institutional review boards (IRBS) and can help as training tools.